1. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. BrJ7 Obstet Gynaecol;Magos, A.L.; Brewster, E.; Singh, R.; O'Dowd, T.; Brincat, M.; Studd, J.W.W.
2. Cell labelling with colloidal substances in whole blood;Schroth, H.J.; Oberhausen, E.; Berberich, R.;Eur J Nucl Med; 6: points raised. Firstly, Mr Prescott suggests that the comprofound haemodynamic effect of somatostatin on renal function. The precise mechanism of this 469-72. ponents of our combined treatment-oestradiol effect is unknown but is likely to be due to a direct,1981
3. Radiochemistry and implant and cyclical norethisterone-should have or indirect action on the smooth muscle vasculabiostability of autologous leucocytes labelled with Tc-99mstannous colloid in whole blood;Hanna, R.; Braun, T.; Levendel, A.; Lomas, F.;EurJNuclMed,1984
4. Saverymuttu SH, Forster AM, Laidler been compared with each other in an attempt to identify the specific therapeutic component. Not ture. The authors mentioned the inhibitory effect of somatostatin on glucagon secretion but did not JB, Lavender JP. Evaluation of Tc-99m tin colloid as a only would such an approach greatly have reduced consider it as a likely explanation. selective in-vitro cell labelling agent for phagocytic cells in the power of the study without a considerable We would like to suggest that the effect of whole blood;Danpure, H.J.; Osman, S.,1985
5. Techniques of leucocyte increase in the number of patients participatsomatostatin on the renal haemodynamic function harvesting and labelling: problems and pespectives. Sem Nucl ing but, more importantly, it would have been is mediated by its inhibitory action on the secretion Med;McAfee, J.G.; Subramanian, G.; Gagne, G.,1984